Hoth Therapeutics News

Hoth Therapeutics | 8-K: Current report

Nov 20 21:32

Hoth Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 13 05:46

Hoth Therapeutics | 424B5: Prospectus

Nov 13 00:33

Hoth Therapeutics | 8-K: Current report

Nov 9 06:36

Hoth Therapeutics | 8-K: Current report

Nov 2 04:18

Hoth Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pavell Jeff

Aug 22 04:21

Hoth Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Sarnoff David

Aug 22 04:21

Hoth Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Knie Robb

Aug 22 04:21

Hoth Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Linsley Wayne

Aug 22 04:21

Hoth Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Knie Robb

Aug 19 20:02

Hoth Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 17 04:19

Hoth Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 10 04:08

Hoth Therapeutics | 8-K: Current report

Aug 8 04:19

Hoth Therapeutics | ARS: Annual Report to Security Holders

Jun 18 18:17

Hoth Therapeutics | DEFA14A: Others

Jun 18 18:13

Hoth Therapeutics | DEF 14A: Definitive information statements

Jun 18 18:13

Hoth Therapeutics | 8-K: Current report

Jun 18 04:45

Hoth Therapeutics | 10-Q: Q1 2024 Earnings Report

May 15 04:06

Hoth Therapeutics | 424B3: Prospectus

Apr 23 04:17

Hoth Therapeutics | EFFECT: Others

Apr 22 18:06